Financial Performance Analysis of Pharmaceutical Industry in India

The financial assessment of a company has been the topic of debate among policy leaders as administrators, planners, economists and research workers for several years. It is a method of calculating the effects of monetary policies and activities of a company. Financial performance review shall involve the examination and evaluation of the financial results in such a manner as to allow a complete diagnostic of the viability and financial soundness of the company. This study is based upon the 5 Pharma companies i.e., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Limited, Cipla Limited, Lupin Limited and Aurobindo Pharma Limited were selected for the study with the period of study from March 2016 to March 2020. The ANOVA analysis result revealed that there is a significant difference in the Profit of the selected pharmaceutical companies during the period of study.